AzTrials
AzTrials

Intimate Partner ViolenceNCT02765139

Preventing Intimate-partner Violence: Impact Evaluation of Engaging Men Through Accountable Practice in Eastern DRC

A study testing Engaging Men through Accountable Practice and Alternative intervention in people with Intimate Partner Violence and Domestic Violence, run by World Bank at 2 sites in Democratic Republic of the Congo.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of the study is to evaluate the impact of Engaging Men in Accountable Practice (EMAP) on the prevention of violence against women and girls in North and South Kivu (DRC). The study is conducted jointly by the World Bank's Africa Gender Innovation Lab and the International Rescue Committee (IRC). Read more about this study

Who is it for?
Ages 20 years and older, men onlyHealthy volunteers can take part
What is being tested?
Engaging Men through Accountable Practice and Alternative intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,387 participants
Where
2 sitesDemocratic Republic of the Congo
Study dates
Feb 2016to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 20 or older but preferably at least 25;
  • Resident of their village, having lived in the community for a minimum of six months with plans to continue living there for at least the coming six months;
  • Ability to participate actively in group work and reflection activities;
  • Commitment to attend meetings, sessions and other activities regularly without incentives;
  • Commitment to non-violence toward women and girls for the duration of the EMAP intervention;

Who cannot join

  • Involved in the IRC-led adolescent girl intervention (COMPASS).

Trial locations and contacts

2 sites in 1 country.

Democratic Republic of the Congo2 sites
  • International Rescue Committee

    Bukavu

  • International Rescue Committee

    Goma

Other trials in Democratic Republic of the Congo

About this study

The objective of the study is to evaluate the impact of Engaging Men in Accountable Practice (EMAP) on the prevention of violence against women and girls in North and South Kivu (DRC). The study is conducted jointly by the World Bank's Africa Gender Innovation Lab and the International Rescue Committee (IRC). EMAP is a program developed and implemented by the IRC to engage men to reflect on how to reduce and prevent intimate partner violence through 16 weekly group discussion sessions. The study is a cluster randomized control trial in which two groups of 25 self-selected men in 15 communities receive the EMAP intervention while in 15 other communities, 50 self-selected men receive an alternative intervention. Key outcomes examined include: (i) Experience of past year physical, sexual and psychological violence reported by women whose partners are EMAP participants; (ii) Participant's gender attitudes and behaviors, conflict and hostility management skills; (iii) Power sharing and communication within the couple.

Being tested
Engaging Men through Accountable Practice, Alternative intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Engaging Men through Accountable PracticeBehavioural

    Engaging Men through Accountable Practice aims to engage men as agents of change through structured, weekly discussions with committed groups of men. It aims to address entrenched views of gender roles and identify positive models of masculinity. The approach follows a structured series of discussions designed to explore existing understandings of masculinity and create more positive models of what it means to be a 'good' man, promoting self-reflection and pushing men to analyze and change their own power and privilege. This methodology begins with a series of discussions with women to inform men's dialogue groups, and includes continuous feedback loops with women throughout the process so that the work with men is grounded in, and accountable to, women's views and objectives.

  • Alternative interventionOther

    Control communities will receive an alternative intervention focused on a non-gender topic of 16 weekly sessions for men only.

Study groups in NCT02765139
Study groupRoleWhat they receive
EMAP TreatmentExperimentalEngaging Men through Accountable Practice: 30 communities are matched into 15 pairs on a set of socio-demographic characteristic and within each pair, 15 treatment sites are randomly selected. Within each treatment community, all adult men (20+ years old) are eligible to participate in the EMAP intervention. A random draw of 50 participants determines who will participate in EMAP in case more than 50 eligible men express interest.
Receives: Behavioral: Engaging Men through Accountable Practice
ControlOtherIn the 15 control sites, the male participants will receive an alternative intervention focused on a non-gender topic of 16 weekly sessions for men only.
Receives: Other: Alternative intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in baseline prevalence of intimate-partner violence

    Change in the % of women who self-report experience of violence by their male partner. The women interviewed are the partners of the male study participants.

    Measured: Baseline, 12 months follow-up

Secondary outcomes (2)
  1. Change in acceptability of intimate partner violence

    Change in the % of women (partners of participants) and men (participants) who report that violence is acceptable in at least one of the situations listed in the survey.

    Measured: Baseline, 12 months follow-up

  2. Change in intention to commit violence

    Change in the % of male participants who report that they are likely to become violent in a list of situations. Scale used: Proximal Antecedents to Violent Episodes.

    Measured: Baseline, 12 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,387 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02765139
Sponsor's protocol ID
P149394
Status last verified
May 2018
First submitted
4 May 2016
Last updated
21 May 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The World Bank has an open data policy, and the de-identified, anonymized data will be published online after the study is completed.

Publications

  • Gurbuz Cuneo A, Vaillant J, Koussoube E, Pierotti RS, Falb K, Kabeya R. Prevention, Cessation, or harm reduction: Heterogeneous effects of an intimate partner violence prevention program in eastern Democratic Republic of the Congo. PLoS One. 2023 Mar 8;18(3):e0282339. doi: 10.1371/journal.pone.0282339. eCollection 2023.

    PubMed 36888613
  • Vaillant J, Koussoube E, Roth D, Pierotti R, Hossain M, Falb KL. Engaging men to transform inequitable gender attitudes and prevent intimate partner violence: a cluster randomised controlled trial in North and South Kivu, Democratic Republic of Congo. BMJ Glob Health. 2020 May;5(5):e002223. doi: 10.1136/bmjgh-2019-002223.

    PubMed 32467354

Questions about this trial

What is this clinical trial studying?

A study testing Engaging Men through Accountable Practice and Alternative intervention in people with Intimate Partner Violence and Domestic Violence, run by World Bank at 2 sites in Democratic Republic of the Congo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Democratic Republic of the Congo. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in baseline prevalence of intimate-partner violence (time frame: Baseline, 12 months follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02765139, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in